Moderna shares hit by COVID-19 vax trial delay report, but biotech says July start still on track Regeneron kicks off prevention trial for COVID-19 antibody cocktail Incensed Applied Therapeutics vows to end 'criminal activity' from short report Sponsored: Keep post-pandemic trials on track: how the right clinical supply chain partner helps sponsors avoid trial disruption, now and going forward Boehringer creates Shanghai hub to connect with Chinese R&D groups British biotech Mission dubs Pfizer lead investor and new R&D partner Sanofi, GlaxoSmithKline near $625M COVID-19 vaccine supply deal with U.K. government: report FDA approves Abbott's Bluetooth-connected pacemaker, defibrillator implants Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease Featured Story | By Ben Adams Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report by Stat said the biotech would have to delay the start of its major phase 3 pandemic vaccine trial. read more |
| |
|---|
|
Top Stories By Amirah Al Idrus A month after moving its COVID-19 antibody cocktail into human trials, Regeneron is starting a phase 3 study to see whether the drug can ward off infection in people exposed to COVID-19 patients. To be conducted with the National Institute of Allergy and Infectious Diseases, the trial aims to enroll 2,000 patients through about 100 sites in the U.S. read more By Ben Adams Short reports are nothing new, but the aggressive “I’m coming after you” PR from Applied Therapeutics certainly is. read more Monday, July 6, 2020 Facing a new reality, pharma and biotech companies must address ongoing clinical trial distribution challenges. Here's how a supply chain partner can help keep your post-pandemic clinical program on track. read more By Nick Paul Taylor Boehringer Ingelheim has opened a site in Shanghai to connect its R&D, business development and venture capital groups to Chinese drug developers. The site brings together all the units involved in the identification and support of promising drug development projects. read more By Ben Adams Pfizer is deepening its already long-term investment and partnership strategy with U.K.-based biotech Mission Therapeutics and its work on selectively inhibiting deubiquitylating enzymes. read more By Angus Liu As COVID-19 vaccines near final stages of testing, governments are also racing against each other, busy securing supply for their own countries. The U.K. government, on the heels of locking up delivery from AstraZeneca, is reportedly ready for more doses from an alliance between Sanofi and GlaxoSmithKline. read more By Conor Hale Abbott has secured approvals from the FDA for its new generation of connected pacemakers and defibrillator implants. read more By Arlene Weintraub Biogen has formed a research pact with Harvard’s Massachusetts Eye and Ear to develop a gene therapy for an inherited form of retinitis pigmentosa caused by mutations in the gene PRPF31. If it succeeds, it could help even more patients than the FDA-approved gene therapy for retinitis pigmentosa, Spark Therapeutics' Luxturna, the researchers believe. read more Resources Sponsored by: Cambrex The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities, and employees than ever before, our experts have contributed more articles to our biggest eBook yet. Sponsored by: EVERSANA How predictive analytics and machine learning have the potential to transform healthcare by predicting “Patient Switching Behaviors.” Sponsored by: Recro Gainesville Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project. Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. Sponsored by: Systech Get an inside look… Merck shares its next-generation approach to supply chain protection with new digital platforms, including Blockchain. Sponsored by: Automation Anywhere Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 